SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Measuring routine childhood vaccination coverage in 204 countries and territories, 1980-2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1.

GBD 2020, Release 1, Vaccine Coverage Collaborators (2021) Measuring routine childhood vaccination coverage in 204 countries and territories, 1980-2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1. Lancet, 398 (10299). pp. 503-521. ISSN 1474-547X https://doi.org/10.1016/S0140-6736(21)00984-3
SGUL Authors: Pollok, Richard Charles G

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (2MB) | Preview
[img]
Preview
PDF (Supplementary appendix) Published Version
Available under License Creative Commons Attribution.

Download (93MB) | Preview

Abstract

BACKGROUND: Measuring routine childhood vaccination is crucial to inform global vaccine policies and programme implementation, and to track progress towards targets set by the Global Vaccine Action Plan (GVAP) and Immunization Agenda 2030. Robust estimates of routine vaccine coverage are needed to identify past successes and persistent vulnerabilities. Drawing from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2020, Release 1, we did a systematic analysis of global, regional, and national vaccine coverage trends using a statistical framework, by vaccine and over time. METHODS: For this analysis we collated 55 326 country-specific, cohort-specific, year-specific, vaccine-specific, and dose-specific observations of routine childhood vaccination coverage between 1980 and 2019. Using spatiotemporal Gaussian process regression, we produced location-specific and year-specific estimates of 11 routine childhood vaccine coverage indicators for 204 countries and territories from 1980 to 2019, adjusting for biases in country-reported data and reflecting reported stockouts and supply disruptions. We analysed global and regional trends in coverage and numbers of zero-dose children (defined as those who never received a diphtheria-tetanus-pertussis [DTP] vaccine dose), progress towards GVAP targets, and the relationship between vaccine coverage and sociodemographic development. FINDINGS: By 2019, global coverage of third-dose DTP (DTP3; 81·6% [95% uncertainty interval 80·4-82·7]) more than doubled from levels estimated in 1980 (39·9% [37·5-42·1]), as did global coverage of the first-dose measles-containing vaccine (MCV1; from 38·5% [35·4-41·3] in 1980 to 83·6% [82·3-84·8] in 2019). Third-dose polio vaccine (Pol3) coverage also increased, from 42·6% (41·4-44·1) in 1980 to 79·8% (78·4-81·1) in 2019, and global coverage of newer vaccines increased rapidly between 2000 and 2019. The global number of zero-dose children fell by nearly 75% between 1980 and 2019, from 56·8 million (52·6-60·9) to 14·5 million (13·4-15·9). However, over the past decade, global vaccine coverage broadly plateaued; 94 countries and territories recorded decreasing DTP3 coverage since 2010. Only 11 countries and territories were estimated to have reached the national GVAP target of at least 90% coverage for all assessed vaccines in 2019. INTERPRETATION: After achieving large gains in childhood vaccine coverage worldwide, in much of the world this progress was stalled or reversed from 2010 to 2019. These findings underscore the importance of revisiting routine immunisation strategies and programmatic approaches, recentring service delivery around equity and underserved populations. Strengthening vaccine data and monitoring systems is crucial to these pursuits, now and through to 2030, to ensure that all children have access to, and can benefit from, lifesaving vaccines. FUNDING: Bill & Melinda Gates Foundation.

Item Type: Article
Additional Information: © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Keywords: Child, Diphtheria-Tetanus-Pertussis Vaccine, Global Burden of Disease, Global Health, Humans, Measles Vaccine, Poliovirus Vaccines, Time Factors, Vaccination Coverage, GBD 2020, Release 1, Vaccine Coverage Collaborators, Humans, Diphtheria-Tetanus-Pertussis Vaccine, Measles Vaccine, Poliovirus Vaccines, Time Factors, Child, Global Health, Global Burden of Disease, Vaccination Coverage, 11 Medical and Health Sciences, General & Internal Medicine
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Lancet
ISSN: 1474-547X
Language: eng
Dates:
DateEvent
7 August 2021Published
21 July 2021Published Online
22 April 2021Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
110110Z/15/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
UID/MULTI/04378/2019undação para a Ciência e Tecnologia (FCT)/Ministro da Ciência, Tecnologia e Ensino Superior (MCTESUNSPECIFIED
UID/QUI/50006/2019undação para a Ciência e Tecnologia (FCT)/Ministro da Ciência, Tecnologia e Ensino Superior (MCTESUNSPECIFIED
SFRH/BHD/110001/2015FCTUNSPECIFIED
XMUMRF/2020-C6/ITCM/0004Xiamen University MalaysiaUNSPECIFIED
OPP1182474Bill and Melinda Gates Foundationhttp://dx.doi.org/10.13039/100000865
PubMed ID: 34273291
Web of Science ID: WOS:000681776000024
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/113956
Publisher's version: https://doi.org/10.1016/S0140-6736(21)00984-3

Actions (login required)

Edit Item Edit Item